Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Portfolio Pulse from Avi Kapoor
Several major stocks, including Methanex, Merck, and others, are experiencing declines in Monday's pre-market session. Methanex's shares fell 6.3% after announcing a $2.05 billion acquisition of OCI Global's methanol business. Merck's shares dropped 4.8% following clinical trial results.
September 09, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Methanex shares fell 6.3% in pre-market trading after announcing a $2.05 billion acquisition of OCI Global's methanol business.
The significant drop in Methanex's share price is likely due to investor concerns over the large acquisition cost and its impact on the company's financials.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Merck's shares fell 4.8% in pre-market trading after clinical trial results for Ifinatamab Deruxtecan in lung cancer.
The decline in Merck's share price is likely due to investor reaction to the clinical trial results, which may not have met expectations.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80